@article{APS7719,
author = {Jun-yang Li and Jia-yuan Huang and Meng Li and Han Zhang and Biao Xing and Gong Chen and Dong Wei and Pei-yuan Gu and Wei-xing Hu},
title = {Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit in vitro },
journal = {Acta Pharmacologica Sinica},
volume = {33},
number = {7},
year = {2016},
keywords = {},
abstract = {Aim: To examine the effects of anisomycin on glioma cells and the related mechanisms in vitro.
Methods: The U251 and U87 human glioblastoma cell lines were tested. The growth of the cells was analyzed using a CCK-8 cell viability assay. Apoptosis was detected using a flow cytometry assay. The expression of proteins and phosphorylated kinases was detected using Western blotting.
Results: Treatment of U251 and U87 cells with anisomycin (0.01–8 μmol/L) inhibited the cell growth in time- and concentration-dependent manners (the IC50 values at 48 h were 0.233±0.021 and 0.192±0.018 μmol/L, respectively). Anisomycin (4 μmol/L) caused 21.5%±2.2% and 25.3%±3.1% of apoptosis proportion, respectively, in U251 and U87 cells. In the two cell lines, anisomycin (4 μmol/L) activated p38 MAPK and JNK, and inactivated ERK1/2. However, neither the p38 MAPK inhibitor SB203580 (10 μmol/L) nor the JNK inhibitor SP600125 (10 μmol/L) prevented anisomycin-induced cell death. On the other hand, anisomycin (4 μmol/L) reduced the level of PP2A/C subunit (catalytic subunit) in a time-dependent manner in the two cell lines. Treatment of the two cell lines with the PP2A inhibitor okadaic acid (100 nmol/L) caused marked cell death.
Conclusion: Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit. The regulation of PP2A/C exression by anisomycin provides a clue to further study on its role in glioma therapy.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/7719}
}